Meiji Yasuda Life Insurance Co Decreases Stake in Danaher Corporation $DHR

Meiji Yasuda Life Insurance Co lessened its holdings in shares of Danaher Corporation (NYSE:DHR) by 42.2% in the 2nd quarter, Holdings Channel reports. The fund owned 4,928 shares of the conglomerate’s stock after selling 3,598 shares during the quarter. Meiji Yasuda Life Insurance Co’s holdings in Danaher were worth $939,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of DHR. BlackRock Inc. purchased a new stake in shares of Danaher in the second quarter valued at approximately $10,492,520,000. Norges Bank purchased a new position in Danaher during the fourth quarter worth approximately $2,177,106,000. Jupiter Topco LLC acquired a new position in Danaher during the second quarter worth $1,456,317,000. Generation Investment Management LLP purchased a new stake in Danaher in the 2nd quarter valued at $1,287,949,000. Finally, Bank of America Corp DE purchased a new stake in Danaher in the 2nd quarter valued at $993,846,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

DHR has been the topic of several analyst reports. Evercore reiterated an “outperform” rating and set a $230.00 price target on shares of Danaher in a report on Monday, July 6th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $240.00 price target on shares of Danaher in a research note on Wednesday, July 22nd. Stifel Nicolaus reduced their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Piper Sandler started coverage on shares of Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target on the stock. Finally, Guggenheim lowered their price objective on Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average price target of $228.91.

Danaher Trading Up 0.3%

NYSE DHR opened at $216.41 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The stock has a market capitalization of $152.13 billion, a P/E ratio of 38.44, a PEG ratio of 2.69 and a beta of 0.78. The firm’s 50-day moving average is $199.46 and its two-hundred day moving average is $192.52. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period last year, the business earned $0.77 earnings per share. On average, sell-side analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.